BioVie Statistics

Total Valuation

BioVie has a market cap or net worth of $19.19 million. The enterprise value is -$3.60 million.

Market Cap	19.19M
Enterprise Value	-3.60M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

BioVie has 18.45 million shares outstanding. The number of shares has increased by 199.08% in one year.

Current Share Class	18.45M
Shares Outstanding	18.45M
Shares Change (YoY)	+199.08%
Shares Change (QoQ)	+17.75%
Owned by Insiders (%)	0.50%
Owned by Institutions (%)	5.66%
Float	16.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.88
P/TBV Ratio	0.90
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.32, with a Debt / Equity ratio of 0.02.

Current Ratio	9.32
Quick Ratio	9.09
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.00

Financial Efficiency

Return on equity (ROE) is -93.23% and return on invested capital (ROIC) is -48.44%.

Return on Equity (ROE)	-93.23%
Return on Assets (ROA)	-42.51%
Return on Invested Capital (ROIC)	-48.44%
Return on Capital Employed (ROCE)	-86.79%
Revenue Per Employee	n/a
Profits Per Employee	-$1.38M
Employee Count	14
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -76.22% in the last 52 weeks. The beta is 1.18, so BioVie's price volatility has been higher than the market average.

Beta (5Y)	1.18
52-Week Price Change	-76.22%
50-Day Moving Average	0.97
200-Day Moving Average	1.90
Relative Strength Index (RSI)	50.89
Average Volume (20 Days)	906,055

Short Selling Information

The latest short interest is 1.50 million, so 8.11% of the outstanding shares have been sold short.

Short Interest	1.50M
Short Previous Month	1.07M
Short % of Shares Out	8.11%
Short % of Float	9.32%
Short Ratio (days to cover)	1.93

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.19M
Pretax Income	-36.29M
Net Income	-19.36M
EBITDA	-18.96M
EBIT	-19.19M
Earnings Per Share (EPS)	-$1.66

Full Income Statement

Balance Sheet

The company has $23.15 million in cash and $366,430 in debt, giving a net cash position of $22.79 million or $1.23 per share.

Cash & Cash Equivalents	23.15M
Total Debt	366,430
Net Cash	22.79M
Net Cash Per Share	$1.23
Equity (Book Value)	21.82M
Book Value Per Share	1.18
Working Capital	21.17M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-17.42M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioVie does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-199.08%
Shareholder Yield	-199.08%
Earnings Yield	-100.90%
FCF Yield	n/a

Analyst Forecast

The average price target for BioVie is $30.00, which is 2,784.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	2,784.62%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 6, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Aug 6, 2024
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2